China Food and Drug Administration, Decision on Revising Matters Relevant to the Administration of the Registration of Imported Pharmaceuticals (Draft for Comments)

国家食品药品监督管理总局关于调整进口药品注册管理有关事项的决定 (征求意见稿)

May 9, 2017
Issued: March 17 2017   Main contents: With a view to encouraging the simultaneous conduct of foreign and domestic clinical trials, after approval,…
SHARE

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

This premium content is reserved for
China Law & Practice Subscribers.

Benefits Include:

  • Unlimited access to Chinalawandpractice.com site and digital newsletters
  • 5 free articles across the ALM subscription network every 30 days
  • Exclusive discounts on ALM events and publications

Continue reading by getting
started with a subscription.

Subscribe Now For Unlimited Access